Renalytix LinkedIn Contact Us
Renalytix Investors

Shareholder Information

The information on this page was last updated on 17 December 2024. The number of shares in issue was 331,206,012.

Significant Shareholdings

ShareholderNumberOrdinary Shares %
Icahn School of Medicine at Mount Sinai37,346,47611.3%
CVI Investments, Inc.33,000,00010.0%
Ruffer LLP28,500,0008.6%
Polar Capital27,520,0168.3%
Jefferson River Capital LLC19,644,3915.9%
Unicorn Asset Management Limited18,955,7775.7%
Pentwater Capital Management LP17,946,2985.4%
Christopher Mills*14,561,3454.4%
Nathaniel Philip Victor James Rothschild10,232,5223.1%

Director Shareholdings

DirectorNumberOrdinary Shares %
Christopher Mills*14,561,3454.4%
James McCullough**3,242,0961.0%
Julian Baines1,848,7000.6%
Fergus Fleming653,0230.2%
Catherine Coste279,8660.1%

* Christopher Mills is partner and Chief Investment Officer of Harwood Capital LLP. Harwood Capital LLP is Investment Manager to North Atlantic Smaller Companies Investment Trust plc and investment adviser to Oryx International Growth Fund Limited. Christopher’s shareholding disclosure is held by North Atlantic Smaller Companies Investment Trust PLC, Oryx International Growth Fund Limited and Harwood Capital LLP.

** James McCullough shareholding includes shares held through his family trust, The McCullough 2020 Irrevocable Trust (the “Trust”).

Shares not in public hands

As of 17 December 2024 the percentage of AIM securities not in public hands was 27.55%. The securities not in public hands include all significant shareholders over 10%, the directors and executive officers who are classed as persons discharging managerial responsibilities. There are no shares held in treasury.

Rights of shareholders

The rights of shareholders are governed by UK law.

Restrictions in transfer of ordinary shares

There are no restrictions on the transfer of the company’s ordinary shares.

UK City Code on Takeover and Mergers

The Company is subject to the provisions of the City Code on Takeover and Mergers.

Other exchanges and trading platforms

All of the Company’s shares are traded on AIM, a market of London Stock Exchange plc, and American Depositary Shares representing the Company’s ordinary shares are listed on the OTCQB. The Company’s shares are not traded on any other exchange or trading platform.

The Company is subject to the UK City Code on Takeovers and Mergers.